Gene · 1778
DYNC1H1: dynein cytoplasmic 1 heavy chain 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DYNC1H1: dynein cytoplasmic 1 heavy chain 1. Genes, record 1778. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1778
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q14204 | Cytoplasmic dynein 1 heavy chain 1 | 4,646 | 97 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44481 | Q14204 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 7317 | Q14204 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 7263 | Q14204 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 7263 | Q14204 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 7317 | Q14204 | Espacenet |
| JP 2023551068 A | 2023-12-06 | 236 | Q14204 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 111 | Q14204 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 26127 | Q14204 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 129098 | Q14204 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 3333 | Q14204 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,266
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DYNC1H1 papers | Newest fiscal year |
|---|---|---|---|
| P40OD010440 | Caenorhabditis Genetics Center | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| R01NS058721 | ACC: Callosal Agenesis as a Window into Common Neurodevelopmental Disorders | 6 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 5 | 2025 |
| R01NS032457 | Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage | 5 | 2025 |
| R35GM141825 | Mechanisms of microtubule-based transport | 4 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 3 | 2025 |
| R35GM124889 | Coordination of molecular motor activity in intracellular transport and assembly of cytoskeletal archit | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
1 to 10 of 1,266Source NIH's project files
See all 1,266 nih grantsPapers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole-Body Muscle MRI in Non-5q Spinal Muscular Atrophy: Patterns, Genotype Prediction, and Diagnostic Implications. | Neurol Genet | 2026 | 42662709 | PubTator, text mining | PubMed |
| Landscape of parental postzygotic mutations across >11,000 rare disease trios. | Am J Hum Genet | 2026 | 42442367 | PubTator, text mining | PubMed |
| Genetic causes of the lissencephaly spectrum: insights from chromosomal microarray and clinical/whole-exome sequencing. | Croat Med J | 2026 | 42286901 | PubTator, text mining | PubMed |
| An engineered streptavidin condensate platform for chemically inducible control of endogenous proteins in mammalian cells. | bioRxiv | 2026 | 42244538 | PubTator, text mining | PubMed |
| The P3018S disease variant reveals how dynein's trailing motor sets ensemble velocity. | bioRxiv | 2026 | 42239374 | PubTator, text mining | PubMed |
| Development of Predictive Models for NB-UVB Treatment Efficacy and Safety in Psoriasis. | Psoriasis (Auckl) | 2026 | 42220473 | PubTator, text mining | PubMed |
| FOSL2 drives transcriptional activation of super‑enhancer-regulated DYNC1H1 to promote hypoxia‑induced oral squamous cell carcinoma progression. | Mol Med Rep | 2026 | 42212377 | PubTator, text mining | PubMed |
| Gene-specific long-term course, neurodevelopmental outcome and quality of life in patients with LIS1/PAFAH1B1-, DCX-, DYNC1H1-, TUBA1A- and TUBG1-related lissencephaly. | Orphanet J Rare Dis | 2026 | 42177523 | PubTator, text mining | PubMed |
| Generation of iPSC line NIMHi033-A from an Indian patient with Autism Spectrum Disorder carrying mutation in DYNC1H1 gene. | Stem Cell Res | 2026 | 42056834 | PubTator, text mining | PubMed |
| Enlarging the phenotypical spectrum of DYNC1H1-related epilepsy. | Neurol Sci | 2026 | 42043625 | PubTator, text mining | PubMed |
1 to 10 of 1,564
See all 1,564 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1778
GET https://conductscience.org/api/genes/v1/1778/patents?page=2